ResultsMoneycontrol
Beta Drugs Standalone September 2026 Net Sales at Rs 58.01 crore, up 6.48% Y-o-Y
Positive+63
GreyOak summary
Beta Drugs reported standalone net sales of Rs 58.01 crore for September 2026, a 6.48% increase from the previous year. Quarterly net profit surged 145.08% to Rs 3.71 crore, while EPS rose to Rs 3.29. The company's shares closed at Rs 1,871.00 on November 9, 2026.
What it affects
- Beta DrugsBETAPositive +63
Net sales and profit rose significantly.Rolling sentiment Positive +47
Source
Read the original at MoneycontrolMore Beta Drugs news
- Beta Drugs Consolidated September 2026 Net Sales at Rs 137.49 crore, up 32.99% Y-o-YMoneycontrol · Results ·